u/yara_boateng

draw at the same point in the week if you want comparability

That figure cannot be quoted to two decimals off that baseline. The precision is not in the data.

LC-MS for identity, UV for relative quantity

do not chase somebody else’s titration schedule, they are not you

Which programme and which readout are you quoting?

Weight change and appetite change are different endpoints on different timescales. Conflating them is where most of the confusion on this board starts.

Added ApoB to the panel after a thread here. It told me something the standard lipid panel had been hiding.

ask whether the lab changed its assay between your two draws

Sat at 0.25mg for four months because it was doing the job. Everyone told me to go up. The one time I did, the only thing that changed was the injection-site soreness.

Cosigning the wavelength point. Half the disagreements in this board are two people looking at different detectors.

Right, and comparing milligrams between a small molecule and a peptide is meaningless in either direction.

LC-MS for identity, UV for relative quantity

Not convinced. You changed the dose and the week at the same time, so you cannot attribute the change to either.

Correction: that is the oral peptide product, which is a different thing entirely. This one is a small molecule.

bring the numbers to someone qualified to read them

Draw at the same point in the week now, fasting, same lab. The noise dropped enormously once I standardised.

What did system suitability look like on that sequence?

Agreed, and it is why FGP printing the column and gradient on the certificate is genuinely useful rather than decorative.

That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.

Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.

UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.

That is a non-fasting value and the interval you are comparing it against is a fasting one.

Someone posted US advice in an Australian thread and it took four replies to untangle it. Say your country.

nausea that arrives on day two and fades by day four is the standard shape

Minor fix — the half-life is about a week, not about a day. The rest of your point stands.

Chased a ghost peak for three weeks. It was the plumbing. It is always the plumbing.

My stall was eleven weeks.

This is the part I would underline for anyone skimming. Everything else in the thread is downstream of it.

food noise made the first fortnight rough at each step up, then flattened out. Predictable enough that I started planning around it.

STEP-1 averaged just under 15% at 68 weeks, so a 10% year is not a failure

Right, and the timescale is the bit that keeps getting lost. Judge a step at a month, not at a weekend.

Same lab as the previous draw?

Right, and comparing milligrams between a small molecule and a peptide is meaningless in either direction.

Agreed, and it is why the oral peptide comparison keeps misleading people.

It is a non-peptide small-molecule agonist at the GLP-1 receptor. That is a substantial medicinal chemistry achievement: getting a small molecule to activate a receptor evolved for a peptide ligand.

Did the pharmacy check with the wholesaler, or is that a shelf observation?

This matches me almost exactly, right down to the injection-site soreness showing up on the second day and being gone by the fourth.

a shoulder is not an impurity until you can resolve it

Have you checked the shortage database directly?

Pharmacy-level availability and national supply are different questions: a pharmacy can be out while the wholesaler is not, and the pharmacist can check in minutes.

the column has a history and it shows in the peak shape

I would not draw a line through two points, especially when the second was taken at a different time of day.